Schedule 13G ownership disclosure

CHEMOMAB THERAPEUTICS LTD

Ordinary Shares / American Depositary Shares · CUSIP: 16385C104

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 32,282,680 · Class: 8.4%

  • Morgan Stanley & Co. LLC

    Shares: 28,786,680 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-25-000481
Form type
SCHEDULE 13G
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
Aug 07, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub